SafeStitch Medical Inc.
Division of TransEnterix Inc.
Latest From SafeStitch Medical Inc.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August through September 2013.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced August-September 2013.
House GOP freshman renew efforts to repeal the device tax. Minimally invasive surgery companies to merge. Medtronic submits the first module of the PMA for its drug-eluting balloon. More news.
Hernia repair is a staple of the general surgeon’s practice, with more than two million procedures performed annually worldwide. However, the procedure has proven problematic due to the mesh products used to repair the hernia defect and their potential to cause complications over time. At the Fifth International Hernia Congress, held recently in New York City, physicians debated the pros and cons of the many hernia repair mesh products that are now available. Although the general consensus at the meeting was there is no “ideal mesh,” mesh manufacturers continue to innovate in this field, offering a host of new products for this $500+ million market, including a variety of biologic meshes for complex repairs, synthetic meshes with biologic-like properties, fully resorbable meshes, and meshes with bacteriostatic properties.
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices
- Therapeutic Areas
- Metabolic Disorders
- Cellular Technical Services Co. Inc.
- North America
- Parent & Subsidiaries
- TransEnterix Inc.
- Senior Management
Jeffrey G Spragens, Pres. & CEO
James J Martin, CFO
Charles J Filipi, MD, Chief Medical Dir.
- Contact Info
SafeStitch Medical Inc.
Phone: (305) 575-4600
4400 Biscayne Blvd., Ste. 570
Miami, FL 33137
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.